DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
02 1LOTREL
03 2ZONISAMIDE
01 120364
02 177183
03 177215
04 177644
05 177869
06 178381
01 6No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Drug : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77183
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Drug : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 78381
Country : US
Patented : No
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Drug : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77215
Country : US
Patented : No
Drug : ZONISAMIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77869
Country : US
Patented : No
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Drug : LOTREL
Dosage Form : CAPSULE; ORAL
Application Number : 20364
Country : US
Patented : No
Drug : ZONISAMIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77644
Country : US
Patented : No
LOOKING FOR A SUPPLIER?
